Get Social With Us

The State of Biomanufacturing Capacity – Do We Finally Have Enough?

Presented at: IBC’s BioProcess International World Conference and Exhibition Boston, MA, September 19, 2005

As development commercialization of new biopharmaceutical products continues, BioProcess Technology Consultants has updated its in-depth analysis of the supply and demand for biomanufacturing capacity. This analysis indicates demand for cell culture manufacturing capacity will continue to increase with supply roughly matching this demand as several companies bring new and/or renovated facilities online. Access to capacity and availability of capacity for companies seeking to outsource production may result in short-term constraints.